ASO Author Reflections: Identification of Prognostic Factors for Stage-III Pancreatic Ductal Adenocarcinoma patients
Ann Surg Oncol
.
2022 Mar;29(3):1616-1617.
doi: 10.1245/s10434-021-11041-7.
Epub 2021 Nov 20.
Authors
Amrita Chattopadhyay
1
,
Chien-Hui Wu
2
3
,
Yu-Wen Tien
3
,
Tzu-Pin Lu
4
5
6
Affiliations
1
Bioinformatics and Biostatistics Core, Center of Genomic and Precision Medicine, National Taiwan University, Taipei, Taiwan.
2
Department of Public Health, Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan.
3
Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.
4
Bioinformatics and Biostatistics Core, Center of Genomic and Precision Medicine, National Taiwan University, Taipei, Taiwan.
[email protected]
.
5
Department of Public Health, Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan.
[email protected]
.
6
Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.
[email protected]
.
PMID:
34802101
DOI:
10.1245/s10434-021-11041-7
No abstract available
MeSH terms
Carcinoma, Pancreatic Ductal* / therapy
Humans
Pancreatic Neoplasms* / therapy
Prognosis